This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More
  • Latest Dividend: 0.80
  • Latest Dividend Yield: 4.36%
  • Dividend Ex-Date: 11/06/14
  • Price Earnings Ratio: 81.0778
  • Price Earnings Comparisons:
    HCN Sector Avg. S&P 500
    81.08 82.00 26.03
  • Price Performance History
    (% change):
    3 Mo 1 Yr 3 Yr
    9.45% 29.89% 52.62%
  • GROWTH 12 Mo 3 Yr CAGR
    Revenue 61.40 3.50 0.64
    Net Income -53.10 0.03 0.01
    EPS -70.70 -0.67 -0.30
  • Earnings for HCN:
    EBITDA 560,605,000
    REVENUE 2.88B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $1.03 $1.07 $4.12 $4.36
Number of Analysts 10 8 10 13
High Estimate $1.05 $1.09 $4.15 $4.45
Low Estimate $1.00 $1.04 $4.10 $4.25
Prior Year $0.99 $1.00 $3.81 $4.12
Growth Rate (Year over Year) 3.54% 6.63% 8.06% 5.87%
HCN News

HCN Health Care REIT Inc.

Analysts Ratings for HCN

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 5 5 4 5
Moderate Buy 1 1 1 1
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 2 2 2
GET HCN ANALYST REPORT

Brokerage Partners

HCN Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs